Quang X. Pham, Chairman, CEO and Interim CFO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 22,385 shares at $4.38 ($93K) on 2026-06-08, disclosed to the SEC on 2026-06-10.
Scheduled sale ($93k) by Chairman, CEO and Interim CFO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.38 | 5,893 | $26K | 27.7% |
| 2 | $4.06 | 12,992 | $53K | 56.5% |
| 3 | $4.21 | 3,500 | $15K | 15.8% |
| Total | $4.17 avg | 22,385 | $93K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |